Host-pathogen interactions of emerging zoonotic viruses: bats, humans and filoviruses.
Hood G. and Carroll M., (2024), Curr Opin Virol
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials.
Chan XHS. et al, (2024), Lancet Microbe
Performance of an envelope glycoprotein-based multiplex immunoassay for Ebola virus antibody detection in a cohort of Ebola virus disease survivors.
Roe MD. et al, (2024), J Virol Methods, 331
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Lim YJ. et al, (2024), Br J Haematol
Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2.
Cornish K. et al, (2024), Open Biol, 14
Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea.
Akoi Boré J. et al, (2024), Nat Commun, 15
Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery.
Ali M. et al, (2024), Clin Exp Immunol
Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials
Chan XHS. et al, (2024)
Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenon.
Mellors J. and Carroll M., (2024), Cell Mol Life Sci, 81
Quantifying human-animal contact rates in Malaysian Borneo: Influence of agricultural landscapes on contact with potential zoonotic disease reservoirs.
Klim H. et al, (2022), Front Epidemiol, 2
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Voysey M. et al, (2021), Lancet, 397, 881 - 891